Effects of hypoxia on the uptake of tritiated thymidine, L-leucine, L-methionine and FDG in cultured cancer cells

Journal of Nuclear Medicine

Volumn 37, Issue 3, 1996, Pages 502-506

  Clavo, Anaira C ^a   Wahl, Richard L ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Amino acid uptake; Fluorine 18 fluorodeoxyglucose; Hypoxia; Nucleotide up take

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE; LEUCINE; METHIONINE; THYMIDINE;

AMINO ACID TRANSPORT; ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CELL VIABILITY; DIAGNOSTIC IMAGING; DNA SYNTHESIS; DRUG UPTAKE; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HYPOXIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TISSUE OXYGENATION;

CELL HYPOXIA; DEOXYGLUCOSE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LEUCINE; MELANOMA; METHIONINE; OVARIAN NEOPLASMS; OXYGEN; THYMIDINE; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; TRITIUM; TUMOR CELLS, CULTURED;

EID: 0030006314     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Wahl RL Positron emission tomography: applications m oncology In I P.C. Murray P Ell, ed Nuclear medicine in clinical diagnosis and treatment Edinburgh, UK: Churchill Livingstone. 1994:801-820.
2. Wahl RL, Zasadny K, Helvie M, Hutchins GD, Weber B, Cody R. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Ontol 1993,11.2101-2111.
3. Koh WJ, Griffin TW, Rasey JS, Laramore GE. Positron emission tomography. A new tool for characterization of malignant disease and selection of therapy Acta Oncol 1994;33 323-327
4. Wahl RL, Quint LE, Cieslak RD, Aisen AM, Koeppe RA, Meyer CR. Anatometabolic tumor imaging, fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med 1993,34.1190-1197.
5. Gray LH, Conger AD, Eben M, Hornsey S, Scott OCA. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy Br J Radiol 1953;26:638-648
6. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955;9:539-549.
7. Brown JM. Evidence for acutely hypoxic cells in mouse tumors and a possible mechanism of reoxygenation. Br J Radiol 1979,52.650-656.
8. Tannock I, Guttman P Response of Chinese hamster ovary cells to anticancer drugs under aerobic and hypoxic conditions Br J Cancer 1981;43:245-248
9. Moulder JE, Rockwell S. Hypoxic fractions of solid tumors, experimental techniques, methods of analysis and survey of existing data. Int J Radiat Oncol Biol Phys 1984,10:695-712
10. Overgaard J. Sensitization of hypoxic tumour cells - clinical experience Int J Radiat Biol 1989,56:801-811.
11. Horsman MR Overgaard J Overcoming tumor radiation resistance resulting from acute hypoxia. Eur J Cancer 1992,717-718.
12. Stone HB, Brown JM, Phillips TL, Sutherland RM. Oxygen in human tumors, correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, MD Radiat Res 1993;136:422-434
13. Wahl RL, Clavo AC, Brown R, Roesner J 2-fluoro-2-deoxy-D-glucose (FDG) uptake into human cancer cells is increased by hypoxia [Abstract]. J Nucl Med 1992;33.841
14. Wahl RL, Clavo AC. Effects of hypoxia on cultured human tumor cell uptake of thymidine, L-methionine and FDG [Abstract] J Nucl Med 1993,34:73
15. Clavo AC, Brown RS, Wahl RL Fluorodeoxyglucose uptake into human cancer cells is increased by hypoxia J Nucl Med 1995;36:1625-1632.
16. Shields AF, Larson SM, Grunbaum Z, Graham MM. Short-term thymidine uptake in normal and neoplastic tissues: studies for PET J Nucl Med 1984;25:759-764.
17. Shields AF, Coonrod DV, Quackenbush RC, Crowley JJ. Cellular sources of thymidine nucleotides studies for PET J Nucl Med 1987,28.1435-1440
18. 11C]methionine in assessment of response m non-Hodgkin's lymphoma [Letter]. Lancet 1990;336:1188
19. Higashi K, Clavo AC, Wahl RL. In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy J Nucl Med 1993;34:773-779.
20. 18F]fluoromisomdazole. Int J Radiat Oncol Biol Phys 1992,22:199-212.
21. Martin GV, Biskupiak JE, Caldwell JH, Rasey JS, Krohn KA. Characterization of iodovinylmisonidazole as a marker for myocardial hypoxia. J Nucl Med 1993,34.918-924
22. Mueller-Klieser W, Vaupel P, Manz R, Schmidseder R Intracapillary oxyhemoglobin saturation of malignant tumors in humans Int J Radiat Oncol Biol Phys 1981;7:1397-1404
23. 31P MR spectroscopy. Am J Roentgenol 1991;157 243-248
24. Hockel M, Vorndran B, Schlenger K. Baussmann E, Knapstein PG. Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix. Gynecol Oncol 1993;51:141-149.
25. Brown JM, Giaccia AJ Tumor hypoxia: the picture has changed in the 1990s Int J Radiat Biol 1994;65 95-102.
26. Roll DE, Murphy BJ, Laderoute KR, Sutherland RM, Smith HC. Oxygen regulated 80 kDa protein and glucose regulated 78kDa protein are identical Mol Cell Biochem 1991,103-141-148
27. Linder KE, Chan YW, Cyr JE, Nowotnik DP, Eckelman WC, Nunn AD. Synthesis, characterization and in vitro evaluation of nitroimidazole - BATO complexes, new technetium compounds designed for imagina hypoxic tissue Bioconj Chem 1993;4 326-333
28. 99mtechnetium-nitroimidazole complex based on a bis(amine-phenol) ligand, comparison to BMS-181321 J Med Chem 1994,37:4155-4163
29. Tubiana M, Pejovic MH, Chavaudra N, Contesso G, Malaise EP The long-term prognostic significance of the thymidine labeling index in breast cancer. Int J Cancer 1984,33 441-445
30. Clark GM, McGuire WL Steroid receptors and other prognostic factors in primary breast cancer Semin Oncol 1988:15:20-25
31. Silvestrini R, Daidone MG, Valagussa P, et al Hydrogen-3-thymidine-labeling index as a prognostic indicator m node-positive breast cancer. J Clin Oncol 1990;8.1321-1326.
32. Trotter GA, Morgan GR, Goeting N, Cooper AJ, Taylor I Prognostic factors and in vitro cytotoxic sensitivity in colorectal cancer. Br J Surg 1984;71 944-946
33. Boccadoro M, Gallamini A, Fruttero A, et al. Plasma cell acid phosphatase activity as prognostic factor in multiple myeloma, relationship to the thymidine-labeling index. J Clin Oncol 1985,3 1503-1507
34. Costa A, Silvestrini R, Grignolio E, Clemente C, Attili A, Testori A. Cell kinetics as a prognostic tool in patients with metastatic malignant melanoma of the skin. Cancer 1987;60:2797-2800
35. Chauvel P, Courdi A, Gioanni J, Vallicioni J, Santini J, Demard F. The labelling index: a prognostic factor in heart and neck carcinoma Radiother Oncol 1989,14:231-237.
36. Alama A, Costantini M, Repetto L, et al. Thymidine labelling index as prognostic factor in resected non-small cell lung cancer. Eur J Cancer 1990;26:622-625
37. Ohyama S, Yonemura Y, Miyazaki I. Proliferative activity and malignancy in human gastric cancers Significance of the proliferation rate and its clinical application Cancer 1992,69:314-321
38. 11C-L and D-methionine in brain tumors Eur J Nucl Med 1985b;10.373-376
39. 11C-L-Methionine. J Neuro Oncol 1986;3.397-404.
40. Fujiwara T, Matsuzawa T, Kubota K, et al. Relationship between histologic type of primary lung cancer and carbon-11-L-methionme uptake with positron emission tomography J Nucl Med 1989,30:33-37
41. 11C-methionine for diagnosis of recurrent brain tumor and radiation injury. Acta Radiol 1991;32:197-202
42. 11C-methionine in breast cancer studied by PET An association with the size of S-phase fraction. Br J Cancer 1991a:64:1121-1124.
43. Miyazawa H, Arai T, Iio M, Hara T PET imaging of non-small-cell lung carcinoma with carbon-11-methionine: relationship between radioactivity uptake and flow-cytometric parameters J Nucl Med 1993;34:1886-1891.
44. Bedford JS, Mitchell JB. The effect of hypoxia on the growth and radiation response of mammalian cells in culture Br J Radiol 1974;47,687-696.
45. Shrieve DC, Deen DF, Harris JW. Effects of extreme hypoxia on the growth and viability of EMT6/SF mouse tumor cells in vitro Cancer Res 1983;43 3521-3527.
46. Spiro IJ, Rice GC, Durand RE, Stickler R, Ling CC. Cell killing, radiosensitazation and cell cycle redistribution induced by chronic hypoxia Int J Radiat Oncol Biol Phys 1984.10 1275-1280.
47. Loffler M. The anti-pyrimidine effect of hypoxia and breqiunar sodium (NSC 368390) is of consequence for tumor cell growth Biochem Pharmacol 1992:43 2281-2287
48. 14C into rat liver protein Am J Physiol 1970.218 842-844.
49. Blomstrand C. Effect of hypoxia on protein metabolism in neuron- and neuroglia cell-enriched fractions from rabbit brain. Exp Neurol 1970,29:175-188.
50. Albrecht J, Smialek M Effect of hypoxia, ischemia and carbon monoxide intoxication on in vivo protein synthesis m neuron and glia cell enriched fractions from rat brain. Acta Neurapathol 1975,31 257-262.
51. Dische S Radiotherapy - new fractionation schemes. Semin Oncol 1994;21 304-310
52. Horsman MR, Khahl AA, Siemann DW, et al. Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation Int J Radiat Oncol Biol Phys 1994,29:439-442
53. Groshar D, McEwan AJ, Parliament MB, et al. Imaging tumor hypoxia and rumor perfusion J Nucl Med 1993;34 885-888.
54. Moore RB, Chapman JD, Mercer JR, et al. Measurement of PDT-induced hypoxia in Dunning prostate tumors by iodine-123-iodoazomycin arabinoside. J Nucl Med 1993;34.405-411
55. Yang DJ, Wallace S, Cherif A, et al Development of F-18-labeled fluoroerythronitroimidazole as a PET agent fur imaging tumor hypoxia Radiology 1995.194 795-800.
56. Chapman JD. Measurement of tumor hypoxia by invasive and non-invasive procedures, a review of recent clinical studies. Radiother Oncol 1991;1.13-19.
57. Kallinowski F, Wilkerson R, Moore R, Strauss W, Vaupel P. Vascularity, perfusion rate and local tissue oxygenation of tumors derived from ras-transformed fibroblasts. Int J Cancel 1991,48 121-127.